The HOXB7 protein promotes breast cancer cell growth through activation of the CCL5/CCR5 pathway in the crosstalk of adipocytes

Simple item page
dc.contributor.advisorJin, Kideok
dc.contributor.authorAkume, Ahone Gina '23
dc.contributor.committeememberDearborn, Richard E.
dc.contributor.committeememberPurington, Lauren C.
dc.date.accessioned2024-11-07T17:52:40Z
dc.date.available2024-11-07T17:52:40Z
dc.date.issued2023-08
dc.descriptionClick on the Resource Link to find this item in the ACPHS Library catalog.
dc.description.abstractHox genes are regulatory genes that encode nuclear proteins acting as transcription factors during normal development and differentiation. One such gene, HOXB7, plays a role in various developmental processes, including hematopoietic differentiation, lymphoid development, and mammary gland development. However, the role of HOX genes in breast cancer development remains largely unexplored. Our previous studies revealed that HOXB7 expression was significantly elevated in primary cancer and distant metastasis. HOXB7 overexpression promoted cell proliferation in SKBR3 breast cancer cells, leading to robustly vascularized xenografts in immunodeficient mice. Furthermore, HOXB7 enhanced tumor growth through TGF-B signaling and recruitment of macrophages, indicating the role of HOXB7 in the crosstalk of stromal components. We found evidence that HOXB7 overexpression in ER+ breast cancer cells promote tumor cell growth through increased expression and signaling of CCL5/CCR5 in crosstalk with adipocytes. By screening secreted factors in adipocytes induced by TCM of MCF-7-HOXB7 cells, it was also found that CCL5 is highly expressed in HOXB7- overexpressing MCF-7 cells. The CCR5 inhibitor, maraviroc, sensitized MCF-7- HOXB7 cells compared to control cells. These findings suggest that blocking the interaction between CCL5 and CCR5 signaling significantly inhibits ER+ breast cancer with HOXB7 overexpression. We aim to further investigate if HOXB7 overexpression in ER+ breast cancer cells promote tumor cell growth through increased expression and signaling of CCL5/CCR5 in crosstalk with adipocytes and the role of CCL5 in breast cancer cell growth and migration.
dc.description.urihttps://acphs.on.worldcat.org/oclc/1467249288
dc.format.extent28 pages
dc.identifier.citationAkume AG. The HOXB7 protein promotes breast cancer cell growth through activation of the CCL5/CCR5 pathway in the crosstalk of adipocytes. Ann Arbor (MI): Proquest LLC; 2023. 28 p.
dc.identifier.thesis30632437
dc.identifier.urihttps://hdl.handle.net/20.500.14303/605
dc.language.isoen_US
dc.publisherProQuest LLC
dc.relation.ispartofAlbany College of Pharmacy and Health Sciences Theses
dc.rightsThis Item is protected by copyright and/or related rights. You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s). http://rightsstatements.org/vocab/InC/1.0/
dc.subjectBreast Neoplasms
dc.subjectAdipocytes
dc.subjectCell Proliferation
dc.subjectMaraviroc
dc.subjectMCF-7 Cells
dc.titleThe HOXB7 protein promotes breast cancer cell growth through activation of the CCL5/CCR5 pathway in the crosstalk of adipocytes
dc.typeThesis
local.departmentprogramDepartment of Pharmaceutical Sciences
Files
Collections
Jin, Kideok Theses Advised
Masters of Science in Pharmaceutical Sciences Theses